National Law Review December 6, 2021
Devaki Patel, David L. Rosen, Jennifer F. Walsh, Jared B. Rifis

On November 16, 2021, U.S. House Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) introduced the highly anticipated Cures 2.0 Act (H.R. 6000). Among other things, this 173-page bipartisan bill contain provisions to accelerate medical research, increase patient access to novel therapeutics, and remove current barriers to telehealth services.

This bill would also create a new agency called Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health (NIH). This agency would be tasked with developing novel treatments to challenging diseases such as cancer, diabetes, ALS, and Alzheimer’s. In a press release, DeGette and Upton said, “By creating ARPA-H, we will be bringing together some of our nation’s greatest minds to help find cures to these devastating...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Cures Act, FDA, Govt Agencies, Provider
Advancing Nationwide, Trusted Health Information Networks
Cures Act tied to quicker release, access of imaging reports
Patient data access speeds up after 21st Century Cures Act
Information Blocking Will Cost Hospitals, Other Providers Under Proposed ONC Rules
OpenNotes Lab to Explore AI’s Impact on Patient-Clinician Communications

Share This Article